CTOs on the Move

Snowden-Pencer Inc

www.snowdenpencer.com

 
Snowden Pencer was founded by Leonard Snowden and George Pencer, both specially trained instrument craftsmen who pioneered important technology in the manufacturing of surgical instruments. This technology used tungsten carbide in the working end of an
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

nContact Surgical

nContact Surgical is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Care Pharmacy Inc

Health Care Pharmacy Inc is a Chapmanville, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Terraboost

Engage with your audience through hand sanitizing billboards. Terraboost Media has established a network of 52,000 boards throughout the top 130 DMAs in supermarkets, drug stores, shopping malls and airports reaching an audience of over 1.4 billion per month. Brands can literally engage with their audience with a dose of wellness and by selecting the vertical networks and/or zip codes, counties that matter. QR codes, brochures, business reply cards and coupons provide advertisers with means of tracking. Join the over 180 satisfied repeat brands who continue to leverage this engaging media platform of which Arbitron research confirms 63% ad recall and 93% positive brand opinion, along with a 30% lift in purchase intent.

MatriCal

MatriCal is a Spokane, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VeriTeQ Corp

VeriTeQ's core technology evolved from implantable radio frequency identification (RFID) microchip technology used in the health care community for over two decades. This first-of-its-kind implantable RFID technology was cleared for use by the FDA in 2004 as a Class II medical device, originally to identify at-risk patients at the point of care. It has now evolved to help medical device manufacturers meet mandatory regulations outlined in the FDA's Safety & Innovation Act, signed into law in July 2012, and the FDA's Unique Device Identification (UDI) Final Rule. This technology is VeriTeQ's Q Inside Safety Technology. VeriTeQ's dosimeter technologies are used in the oncology suite and give an oncology team the ability to measure the dosage of radiation delivered to a patient on a per treatment basis. The data collected from our dosimeter technologies is invaluable when recording the total amount of radiation that a patient is exposed to during the entire treatment regimen, and the data can be used on a generic basis to develop future treatment regimens and evidence-based healthcare. VeriTeQ is developing an informatics and data analytics platform that will improve the type of medical device and treatment regimen data that can be used in many applications to improve patient healthcare and outcomes. Such examples include using VeriTeQ's UDI data in supply chain management for medical device manufacturers and healthcare institutions, quality and reimbursement controls for hospitals, and treatment regimen data for patients receiving chemotherapy and radiation therapy. VeriTeQ owns a rich portfolio of intellectual property protecting all of its current and future technologies.